Niranjan Bose

Niranjan Bose has held various roles throughout their work experience. Niranjan started their career as a Business Analyst at the Bill & Melinda Gates Foundation in 2007 and later became a Program Officer, managing vaccine-related investments for infectious diseases. Niranjan also served as Chief of Staff in the Office of the President, Global Health Program. Bose then joined SDG Life Sciences as a Senior Consultant, where they developed franchise strategies and conducted market research for pharmaceutical companies. Niranjan has also held advisory and board roles in organizations such as Gates Ventures, Alzheimer's Disease Data Initiative, Institute for Health Metrics and Evaluation, Vellore Christian Medical College Foundation, Last Mile Health, and BITSAA Int. Most recently, they served as a Board Member and Interim CEO at GH Labs.

Niranjan Bose holds a PhD in Biochemistry from the Geisel School of Medicine at Dartmouth, which they received from 1998 to 2004. Prior to that, they completed an MS and B Pharm in Biological Sciences and Pharmaceutical Sciences from the Birla Institute of Technology and Science, Pilani, from 1992 to 1997.

Additionally, Niranjan obtained a Business Bridge Diploma from the Tuck School of Business at Dartmouth, although the specific dates of this program are unknown. Niranjan also completed a Certificate Program in Clinical Trials from the University of Washington in 2011-12.

Niranjan has also earned a Certificate of Completion from the Tuck Business Bridge Program, although the specific details regarding the institution and the date of completion are not provided.